Knowledge Translation (KT) is the process of making knowledge created within one professional community accessible, understandable and useful within other professional communities, which leads ultimately to widespread adoption of that knowledge into everyday health practices. But how is this done, and does it have any disruptive effects on Quality Improvement (QI) standards? Joining host Alicia Sutton to speak on this matter is Dr. Robert J. Birnbaum, MD, PhD. Dr. Birnbaum is the Knowledge Translation Research Director for the Massachusetts General Hospital Academy, the Director of Continuing Professional Development at Partners HealthCare, and an Assistant Professor of Psychiatry at Harvard Medical School.
How Knowledge Translation and Quality Improvement Impact Medical Learning

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Knowledge Translation (KT) is the process of making knowledge created within one professional community accessible, understandable and useful within other professional communities, which leads ultimately to widespread adoption of that knowledge into everyday health practices. But how is this done, and does it have any disruptive effects on Quality Improvement (QI) standards? Joining host Alicia Sutton to speak on this matter is Dr. Robert J. Birnbaum, MD, PhD. Dr. Birnbaum is the Knowledge Translation Research Director for the Massachusetts General Hospital Academy, the Director of Continuing Professional Development at Partners HealthCare, and an Assistant Professor of Psychiatry at Harvard Medical School.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?